skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: HighWire Press (Free Journals) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Waking up melanoma
Waking up melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Waking up melanoma

Baek, Amy E.

Science signaling, 2022-06, Vol.15 (739), p.eadd5252-eadd5252 [Periódico revisado por pares]

Washington: The American Association for the Advancement of Science

Texto completo disponível

Citações Citado por
2
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Spencer, Christine N ; McQuade, Jennifer L ; Gopalakrishnan, Vancheswaran ; McCulloch, John A ; Vetizou, Marie ; Cogdill, Alexandria P ; Khan, Md A Wadud ; Zhang, Xiaotao ; White, Michael G ; Peterson, Christine B ; Wong, Matthew C ; Morad, Golnaz ; Rodgers, Theresa ; Badger, Jonathan H ; Helmink, Beth A ; Andrews, Miles C ; Rodrigues, Richard R ; Morgun, Andrey ; Kim, Young S ; Roszik, Jason ; Hoffman, Kristi L ; Zheng, Jiali ; Zhou, Yifan ; Medik, Yusra B ; Kahn, Laura M ; Johnson, Sarah ; Hudgens, Courtney W ; Wani, Khalida ; Gaudreau, Pierre-Olivier ; Harris, Angela L ; Jamal, Mohamed A ; Baruch, Erez N ; Perez-Guijarro, Eva ; Day, Chi-Ping ; Merlino, Glenn ; Pazdrak, Barbara ; Lochmann, Brooke S ; Szczepaniak-Sloane, Robert A ; Arora, Reetakshi ; Anderson, Jaime ; Zobniw, Chrystia M ; Posada, Eliza ; Sirmans, Elizabeth ; Simon, Julie ; Haydu, Lauren E ; Burton, Elizabeth M ; Wang, Linghua ; Dang, Minghao ; Clise-Dwyer, Karen ; Schneider, Sarah ; Chapman, Thomas ; Anang, Nana-Ama A S ; Duncan, Sheila ; Toker, Joseph ; Malke, Jared C ; Glitza, Isabella C ; Amaria, Rodabe N ; Tawbi, Hussein A ; Diab, Adi ; Wong, Michael K ; Patel, Sapna P ; Woodman, Scott E ; Davies, Michael A ; Ross, Merrick I ; Gershenwald, Jeffrey E ; Lee, Jeffrey E ; Hwu, Patrick ; Jensen, Vanessa ; Samuels, Yardena ; Straussman, Ravid ; Ajami, Nadim J ; Nelson, Kelly C ; Nezi, Luigi ; Petrosino, Joseph F ; Futreal, P Andrew ; Lazar, Alexander J ; Hu, Jianhua ; Jenq, Robert R ; Tetzlaff, Michael T ; Yan, Yan ; Garrett, Wendy S ; Huttenhower, Curtis ; Sharma, Padmanee ; Watowich, Stephanie S ; Allison, James P ; Cohen, Lorenzo ; Trinchieri, Giorgio ; Daniel, Carrie R ; Wargo, Jennifer A

Science (American Association for the Advancement of Science), 2021-12, Vol.374 (6575), p.1632-1640 [Periódico revisado por pares]

United States: The American Association for the Advancement of Science

Texto completo disponível

Citações Citado por
3
PET/CT Staging of Malignant Melanoma
PET/CT Staging of Malignant Melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

PET/CT Staging of Malignant Melanoma

The Journal of nuclear medicine (1978), 2020-05, Vol.61 (5), p.20N [Periódico revisado por pares]

New York: Society of Nuclear Medicine

Texto completo disponível

Citações Citado por
4
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

Kuk, Deborah ; Shoushtari, Alexander N. ; Barker, Christopher A. ; Panageas, Katherine S. ; Munhoz, Rodrigo R. ; Momtaz, Parisa ; Ariyan, Charlotte E. ; Brady, Mary Sue ; Coit, Daniel G. ; Bogatch, Kita ; Callahan, Margaret K. ; Wolchok, Jedd D. ; Carvajal, Richard D. ; Postow, Michael A.

The oncologist (Dayton, Ohio), 2016-07, Vol.21 (7), p.848-854 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
5
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity

Ferrari de Andrade, Lucas ; Tay, Rong En ; Pan, Deng ; Luoma, Adrienne M ; Ito, Yoshinaga ; Badrinath, Soumya ; Tsoucas, Daphne ; Franz, Bettina ; May, Jr, Kenneth F ; Harvey, Christopher J ; Kobold, Sebastian ; Pyrdol, Jason W ; Yoon, Charles ; Yuan, Guo-Cheng ; Hodi, F Stephen ; Dranoff, Glenn ; Wucherpfennig, Kai W

Science (American Association for the Advancement of Science), 2018-03, Vol.359 (6383), p.1537-1542 [Periódico revisado por pares]

United States: The American Association for the Advancement of Science

Texto completo disponível

Citações Citado por
6
LPA breakdown in melanoma invasion
LPA breakdown in melanoma invasion
Material Type:
Artigo 		Adicionar ao Meu Espaço

LPA breakdown in melanoma invasion

Journal of cell science, 2017-10, Vol.130 (20), p.e2001-e2001 [Periódico revisado por pares]

Cambridge: The Company of Biologists Ltd

Texto completo disponível

Citações Citado por
7
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response
Material Type:
Artigo 		Adicionar ao Meu Espaço

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

Robbins, Paul F ; Kassim, Sadik H ; Tran, Thai L N ; Crystal, Jessica S ; Morgan, Richard A ; Feldman, Steven A ; Yang, James C ; Dudley, Mark E ; Wunderlich, John R ; Sherry, Richard M ; Kammula, Udai S ; Hughes, Marybeth S ; Restifo, Nicholas P ; Raffeld, Mark ; Lee, Chyi-Chia R ; Li, Yong F ; El-Gamil, Mona ; Rosenberg, Steven A

Clinical cancer research, 2015-03, Vol.21 (5), p.1019-1027 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Goodman, Aaron M ; Kato, Shumei ; Bazhenova, Lyudmila ; Patel, Sandip P ; Frampton, Garrett M ; Miller, Vincent ; Stephens, Philip J ; Daniels, Gregory A ; Kurzrock, Razelle

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2598-2608 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Citações Citado por
9
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

Larkin, James ; Chmielowski, Bartosz ; Lao, Christopher D. ; Hodi, F. Stephen ; Sharfman, William ; Weber, Jeffrey ; Suijkerbuijk, Karijn P. M. ; Azevedo, Sergio ; Li, Hewei ; Reshef, Daniel ; Avila, Alexandre ; Reardon, David A.

The oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.709-718 [Periódico revisado por pares]

United States: AlphaMed Press

Texto completo disponível

Citações Citado por
10
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

McDermott, D. ; Haanen, J. ; Chen, T.-T. ; Lorigan, P. ; O'Day, S.

Annals of oncology, 2013-10, Vol.24 (10), p.2694-2698 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (12.840)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (12.988)
  2. Anais de Congresso  (35)
  3. Reports  (4)
  4. Resenhas  (2)
  5. Mais opções open sub menu

Assunto 

  1. Science & Technology  (10.632)
  2. Life Sciences & Biomedicine  (9.800)
  3. Humans  (9.295)
  4. Melanoma  (5.070)
  5. Animals  (4.947)
  6. Oncology  (4.730)
  7. Mice  (4.154)
  8. Biological And Medical Sciences  (4.080)
  9. Female  (3.770)
  10. Medical Sciences  (3.633)
  11. Melanoma - Pathology  (3.238)
  12. Tumors  (3.114)
  13. Male  (3.086)
  14. Middle Aged  (1.998)
  15. Cell Line, Tumor  (1.975)
  16. Melanoma - Genetics  (1.938)
  17. Melanoma - Metabolism  (1.854)
  18. Melanoma - Immunology  (1.796)
  19. Adult  (1.720)
  20. Aged  (1.619)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1963  (80)
  2. 1963Até1977  (469)
  3. 1978Até1992  (1.916)
  4. 1993Até2008  (4.675)
  5. Após 2008  (5.891)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (13.027)
  2. Japonês  (2.199)
  3. Norueguês  (6)
  4. Francês  (5)
  5. Russo  (2)
  6. Chinês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.